Today's Strong And Under The Radar Stock Is St Jude Medical (STJ)

Trade-Ideas LLC identified St Jude Medical (STJ) as a strong and under the radar candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

St Jude Medical

(

STJ

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified St Jude Medical as such a stock due to the following factors:

  • STJ has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $219.8 million.
  • STJ has traded 654.269000000000005456968210637569427490234375 options contracts today.
  • STJ is making at least a new 3-day high.
  • STJ has a PE ratio of 31.
  • STJ is mentioned 1.23 times per day on StockTwits.
  • STJ has not yet been mentioned on StockTwits today.
  • STJ is currently in the upper 20% of its 1-year range.
  • STJ is in the upper 35% of its 20-day range.
  • STJ is in the upper 45% of its 5-day range.
  • STJ is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in STJ with the Ticky from Trade-Ideas. See the FREE profile for STJ NOW at Trade-Ideas

More details on STJ:

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. The stock currently has a dividend yield of 1.6%. STJ has a PE ratio of 31. Currently there are 3 analysts that rate St Jude Medical a buy, no analysts rate it a sell, and 18 rate it a hold.

The average volume for St Jude Medical has been 4.1 million shares per day over the past 30 days. St Jude Medical has a market cap of $22.2 billion and is part of the health care sector and health services industry. The stock has a beta of 1.14 and a short float of 2.8% with 2.80 days to cover. Shares are up 26.5% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates St Jude Medical as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

Highlights from the ratings report include:

  • STJ's revenue growth has slightly outpaced the industry average of 6.9%. Since the same quarter one year prior, revenues slightly increased by 7.7%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period, despite the company's weak earnings results. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
  • The gross profit margin for ST JUDE MEDICAL INC is currently very high, coming in at 72.65%. Regardless of STJ's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.56% trails the industry average.
  • ST JUDE MEDICAL INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. The company has suffered a declining pattern of earnings per share over the past year. However, we anticipate this trend reversing over the coming year. During the past fiscal year, ST JUDE MEDICAL INC reported lower earnings of $3.08 versus $3.45 in the prior year. This year, the market expects an improvement in earnings ($4.06 versus $3.08).
  • Current return on equity is lower than its ROE from the same quarter one year prior. This is a clear sign of weakness within the company. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, ST JUDE MEDICAL INC's return on equity exceeds that of both the industry average and the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...